This is a randomized controlled trial of telemonitoring vs usual care provided by home care agencies for patients with heart failure. The study hypothesis is that Telemonitoring will reduce hospital re-admission rates, urgent care visits, unscheduled physician appointments, Emergency Room visits in patients with heart failure over the 60 day post hospitalization period.
A 60 day stratified, randomized clinical trial of a home-based telemonitoring system (TEP) vs. usual home-care with educational package (EP). Both Groups will receive intensive patient education and primary care physicians will be prompted to adhere to heart failure management guidelines. The study will be conducted on 100 patients receiving home care nursing services post-hospital discharge. Each participant will be randomized in equal amounts to treatment (TEP) or no treatment (EP).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
99
telemonitoring post hospitalization
The Amount of Time Participants Are Readmitted to the Hospital or Visit the Emergency Department (ED).
Median time to combined endpoint to see if/when the participants need to be readmitted to the hospital or visit the ED
Time frame: Participants were followed for the duration of home care services up to 12 months
Kansas City Cardiomyopathy Questionaire
Health Status, Change in Overall Summary Score minimum: 0 maximum: 100 higher scores=better outcome
Time frame: Participants were followed for the duration of home care services up to 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.